Moderately hypofractionated and conventionally fractionated radiotherapy demonstrate similar efficacy, but one ...

"It’s crucial that patients and their families know about this new option," said Dr. William Russell, an oncology radiologist ...

Outranked only by skin cancer, prostate cancer is the second most common cancer in men in the U.S. Although one in every ...

Recovering erections grabs the attention of most men and their doctors after prostate cancer treatment. A new study redirects ...

The radioligand agent is now approved for use before chemotherapy in patients who have been treated with an androgen receptor ...

The FDA has approved Gozellix (kit for the preparation of gallium Ga 68 gozetotide injection), a radioactive diagnostic agent for prostate cancer detection.

Kidney stones and gallstones may increase the risk for prostate cancer, which could have implications for disease monitoring and prevention in specific populations. Patients with kidney stones or ...

Men who avoided prostate cancer screening appointments were significantly more likely to die from the disease, according to ...

Before a prostate biopsy is performed, various preliminary screening procedures are typically conducted. These include a ...

A new study has revealed that men who don't heed recommendations for prostate cancer screenings are at a significantly higher ...

A clinical trial co-led by Yale Urology showed high resolution micro-ultrasound is an effective tool for guiding prostate ...